Parenteral Drugs (India) reports consolidated net loss of Rs 26.14 crore in the December 2019 quarter
Sales decline 28.88% to Rs 7.24 crore
Net Loss of Parenteral Drugs (India) reported to Rs 26.14 crore in the quarter ended December 2019 as against net loss of Rs 25.25 crore during the previous quarter ended December 2018. Sales declined 28.88% to Rs 7.24 crore in the quarter ended December 2019 as against Rs 10.18 crore during the previous quarter ended December 2018. ParticularsQuarter EndedDec. 2019Dec. 2018% Var.Sales7.2410.18 -29 OPM %-40.88-22.20 -PBDT-31.03-26.70 -16 PBT-35.38-31.33 -13 NP-26.14-25.25 -4Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Feb 12 2020 | 4:01 PM IST